The unique needs of couples experiencing androgen deprivation therapy for prostate cancer
- PMID: 20169495
- DOI: 10.1080/00926230903554552
The unique needs of couples experiencing androgen deprivation therapy for prostate cancer
Abstract
Androgen deprivation therapy (ADT) is being increasingly used to treat men with prostate cancer. ADT has been associated with many side effects that may persist for the lifetime of the patient and can have potentially devastating effects on the quality of life of both men and their intimate relationships. Despite U.S. estimates that more than 40,000 men begin ADT each year and live on average for 10 years, there have been few studies examining the effect of ADT on couples. This article reviews the emerging literature on the challenges faced by men and their partners while undergoing ADT. Loss of libido, erectile dysfunction, genital shrinkage, low self-esteem, and diminished masculinity are commonly associated with undergoing ADT. These losses frequently lead to changes in the marital relationship in areas such as roles and responsibilities, communication, and intimacy. Intervention strategies for helping couples maintain a strong relational bond need to be selected carefully for this population because of these unique and profound changes. Couples who succeed in maintaining sexuality and intimacy have been shown to have higher quality of life and more satisfying relationships.
Similar articles
-
Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.BJU Int. 2008 Jul;102(1):39-43. doi: 10.1111/j.1464-410X.2008.07505.x. Epub 2008 Feb 21. BJU Int. 2008. PMID: 18294309
-
Androgen deprivation therapy: evidence-based management of side effects.BJU Int. 2013 Apr;111(4):543-8. doi: 10.1111/j.1464-410X.2012.11774.x. Epub 2013 Jan 25. BJU Int. 2013. PMID: 23351025 Review.
-
Maintaining intimacy for prostate cancer patients on androgen deprivation therapy.Curr Opin Support Palliat Care. 2016 Mar;10(1):55-65. doi: 10.1097/SPC.0000000000000190. Curr Opin Support Palliat Care. 2016. PMID: 26761788 Review.
-
[An active sex life is possible for men undergoing androgen deprivation therapy for prostate cancer].Ugeskr Laeger. 2015 Jun 8;177(24):V12140703. Ugeskr Laeger. 2015. PMID: 26058525 Review. Danish.
-
A description of heterosexual couples' sexual adjustment to androgen deprivation therapy for prostate cancer.Psychooncology. 2011 Aug;20(8):880-8. doi: 10.1002/pon.1794. Epub 2010 Jul 11. Psychooncology. 2011. PMID: 20623824
Cited by
-
Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy.J Sex Med. 2014 Oct;11(10):2571-80. doi: 10.1111/jsm.12645. Epub 2014 Jul 24. J Sex Med. 2014. PMID: 25059094 Free PMC article. Clinical Trial.
-
Pharmacotherapeutic management of locally advanced prostate cancer: current status.Drugs. 2011 May 28;71(8):1019-41. doi: 10.2165/11591500-000000000-00000. Drugs. 2011. PMID: 21668040 Review.
-
Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer.Cancer Manag Res. 2023 Oct 31;15:1197-1206. doi: 10.2147/CMAR.S421951. eCollection 2023. Cancer Manag Res. 2023. PMID: 37929256 Free PMC article.
-
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots.Asian J Urol. 2017 Oct;4(4):208-222. doi: 10.1016/j.ajur.2017.04.001. Epub 2017 Apr 22. Asian J Urol. 2017. PMID: 29387553 Free PMC article. Review.
-
Quality of life issues in men undergoing androgen deprivation therapy: a review.Asian J Androl. 2012 Mar;14(2):226-31. doi: 10.1038/aja.2011.108. Epub 2012 Jan 9. Asian J Androl. 2012. PMID: 22231296 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical